Biotech

All Articles

Basilea scores $268M BARDA backing for antifungals, antibiotics

.Basilea Pharmaceutica's job building brand new antifungals has actually acquired a substantial incr...

Capricor markets Europe liberties to late-stage DMD treatment for $35M

.Having currently scooped up the U.S. civil rights to Capricor Therapies' late-stage Duchenne muscul...

FDA junks adcomm for Applied's unusual illness medication

.After pushing back the decision date for Applied Rehabs' metabolic condition drug govorestat, the F...

Novo inks $600M NanoVation bargain to study hereditary medicines ex-liver

.Novo Nordisk is actually continuing its own press right into genetic medicines, agreeing to pay Nan...

Innovent links cytokine to intestines cancer actions

.Innovent Biologics has helped make the scenario that its gate inhibitor-cytokine blend protein poss...

Merck, Daiichi ADC hits objective in period 3 lung cancer research

.A stage 3 test of Daiichi Sankyo and Merck &amp Co.'s HER3-directed antibody-drug conjugate (ADC) h...

Rakovina deepens artificial intelligence center with collab to choose cancer cells targets

.5 months after Rakovina Therapeutics rotated toward artificial intelligence, the cancer-focused bio...

Ascendis' dwarfism medication smash hits in stage 3, intimidates BioMarin

.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, stating phase 3 growth ailm...

Despite ph. 3 miss, Alkeus observes course ahead of time for eye illness resource

.Though Alkeus Pharmaceuticals' dental eye health condition property failed to substantially lower g...

Kairos goes social with $6M IPO to cash tests of cancer cells medicine

.With a trio of biotechs striking the Nasdaq on Friday, it was simple to overlook a smaller-scale so...